Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Immunotherapy
  • (-) ≠ Pahl, J.H.W.
  • (-) ≠ Personalized medicine

Refine Results

Resource Type

Availability

Creation Date

Show more

Topic

Show more

Author

Show more

Language

Search results

  • RSS Feed
(25 - 48 of 133)

Pages

Upconversion nanoparticle platform for efficient dendritic cell antigen delivery and simultaneous tracking
Cytokine-mediated regulation of immunity during persistent viral infection
Single agent Talimogene Laherparepvec for stage IIIB-IVM1c melanoma patients: A systematic review and meta-analysis
Systemic therapy in malignant mesothelioma
WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma
Safety and tumour-specific immunological responses of combined dendritic cell vaccination and anti-CD40 agonistic antibody treatment for patients with metastatic pancreatic cancer
Clustering
Endoglin and the immune system
Response to immune checkpoint inhibitors in acral melanoma
Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer
New approaches to imaging and treatment of ocular melanoma
First-line nivolumab plus ipilimumab versus chemotherapy for the treatment of unresectable malignant pleural mesothelioma: patient-reported outcomes in CheckMate 743
Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trial
Conjunctival melanoma: New insights in tumour genetics and immunology, leading to new therapeutic options
Stimulation of the PD-1 pathway decreases atherosclerotic lesion development in Ldlr deficient mice
Cancer vaccine strategies to improve immunotherapy
From immune suppression to immune modulation in type 1 diabetes patients
eNose analysis for early immunotherapy response monitoring in non-small cell lung cancer
Combinatorial prospects of nanoparticle mediated immunotherapy of cancer
Modelling the role of cytotoxic T lymphocytes in tumour regression
Cross-presentation of a TAP-independent signal peptide induces CD8 T immunity to escaped cancers but necessitates anchor replacement
High-dimensional profiling of immunotherapy-responsive immune cells in cancer
Towards a tailored therapeutic approach for vulvar cancer patients
Mathematical modelling based on in vivo imaging suggests CD137-stimulated cytotoxic T lymphocytes exert superior tumour control due to an enhanced antimitotic effect on tumour cells

Pages